
Cell Biology Cloud Computing Market Report 2026
Global Outlook – By Component (Software, Hardware, Services), By Deployment Model (Public Cloud, Private Cloud, Hybrid Cloud), By Application (Research, Drug Discovery, Diagnostics, Personalized Medicine, Other Applications), By End-Use Industry (Pharmaceutical Companies, Biotechnology Firms, Academic And Research Institutions, Healthcare Institutions, Contract Research Organizations) – Market Size, Trends, Strategies, and Forecast to 2035
Cell Biology Cloud Computing Market Overview
• Cell Biology Cloud Computing market size has reached to $3.98 billion in 2025 • Expected to grow to $7.9 billion in 2030 at a compound annual growth rate (CAGR) of 14.7% • Growth Driver: Surge In Demand For Personalized And Precision Medicine Fueling The Growth Of The Market Due To Enhanced Treatment Effectiveness Through Data-driven Insights • Market Trend: High-Speed Cloud Computing Streamlines Phenotypic Screening • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Cell Biology Cloud Computing Market?
Cell biology cloud computing refers to the use of cloud-based platforms and computational resources to perform large-scale biological data analysis and simulations related to cells. It enables researchers to process complex datasets, run modeling experiments, and store results efficiently without relying on local infrastructure. This approach accelerates scientific discovery by providing scalable, on-demand computing power and advanced analytical tools. The main components of cell biology cloud computing include software, hardware, and services. Software refers to cloud-enabled platforms and computational tools designed to manage, analyze, and visualize complex cell biology datasets, facilitating collaboration and accelerating scientific discovery. These solutions are deployed through public cloud, private cloud, and hybrid cloud models. They are applied across research, drug discovery, diagnostics, personalized medicine, and other applications and are utilized by end-use industries including pharmaceutical companies, biotechnology firms, academic and research institutions, healthcare institutions, and contract research organizations.
What Is The Cell Biology Cloud Computing Market Size and Share 2026?
The cell biology cloud computing market size has grown rapidly in recent years. It will grow from $3.98 billion in 2025 to $4.56 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing genomic and proteomic research activities, adoption of local computational infrastructure, growing need for complex cellular simulations, rising investment in academic and research institutions, expansion of pharmaceutical R&D programs.What Is The Cell Biology Cloud Computing Market Growth Forecast?
The cell biology cloud computing market size is expected to see rapid growth in the next few years. It will grow to $7.9 billion in 2030 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to growing deployment of hybrid cloud computing models, increasing integration with AI-enabled analysis platforms, rising demand for large-scale simulation and modeling, expansion of biotech and pharmaceutical cloud initiatives, increasing adoption of collaborative research platforms. Major trends in the forecast period include increasing adoption of cloud-based cell biology platforms, rising demand for high-performance computing for simulations, growing integration of data analysis and visualization tools, expansion of workflow management and collaboration software, rising focus on personalized medicine and drug discovery applications.Global Cell Biology Cloud Computing Market Segmentation
1) By Component: Software, Hardware, Services 2) By Deployment Model: Public Cloud, Private Cloud, Hybrid Cloud 3) By Application: Research, Drug Discovery, Diagnostics, Personalized Medicine, Other Applications 4) By End-Use Industry: Pharmaceutical Companies, Biotechnology Firms, Academic And Research Institutions, Healthcare Institutions, Contract Research Organizations Subsegments: 1) By Software: Data Analysis Tools, Simulation Platforms, Visualization Applications, Collaboration Software, Workflow Management Systems 2) By Hardware: Servers, Storage Devices, Networking Equipment, Workstations, Accelerators 3) By Services: Consulting Services, Cloud Hosting Services, Maintenance And Support, Training And Education, Integration ServicesWhat Is The Driver Of The Cell Biology Cloud Computing Market?
The increasing demand for personalized and precision medicine is expected to drive the growth of the cell biology cloud computing market over the forecast period. Personalized and precision medicine involves tailoring medical treatments based on an individual’s genetic, molecular, environmental, and lifestyle characteristics to improve therapeutic effectiveness and patient outcomes. The rising adoption of these approaches is largely driven by their ability to deliver more targeted therapies, reduce adverse effects, and improve clinical success rates compared to conventional treatment methods. Cell biology cloud computing platforms support personalized and precision medicine by enabling researchers and clinicians to analyze complex cellular and molecular processes using scalable, high-performance computational resources. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit advocacy organization, the US Food and Drug Administration approved 16 new personalized treatments for rare diseases, an increase from six approvals in 2022. Therefore, the increasing demand for personalized and precision medicine is driving the growth of cell biology cloud computing industry.Key Players In The Global Cell Biology Cloud Computing Market
Major companies operating in the cell biology cloud computing market are Siemens AG, Roche Holding AG, Thermo Fisher Scientific Inc, Illumina Inc, QIAGEN Digital Insights, PathAI Inc, LabVantage Solutions Inc, SOPHiA GENETICS SA, Emerald Cloud Lab Inc, Metagenomi Inc, DNAnexus Inc, L7 Informatics Inc, Seqera Labs Inc, Pivot Bio Inc, Genestack Ltd, BioBam Bioinformatics SL, CureMatch Inc, MolecularMatch Inc, Basepair Technologies Inc, and Lamin Labs Inc.Global Cell Biology Cloud Computing Market Trends and Insights
Major companies operating in the cell biology cloud computing market are focusing on developing advanced solutions, such as AI-driven cloud platforms for high-throughput cell morphology analysis, to enhance data processing efficiency, accelerate research, and improve experimental reproducibility. AI-driven cell biology cloud platforms refer to cloud-based systems that leverage artificial intelligence to automatically analyze cellular imaging data, quantify morphological features, and integrate results with bioinformatics pipelines. For instance, in January 2023, ThinkCyte, a Japan-based biotechnology company, unveiled MorphoScan Cloud, a versatile cloud-based platform for AI-driven cell morphology data analysis. This new solution focuses on providing scalable, high-speed analysis of large cellular datasets, which helps researchers accelerate drug discovery, improve phenotypic screening, and optimize experimental design without extensive local computing infrastructure. By leveraging advanced machine learning models and cloud computing resources, the platform enables real-time data processing, collaborative research, and automated reporting. It is engineered to support demanding laboratory and research environments, ensuring consistent, accurate, and scalable performance for cell biology studies, high-content screening, and translational research initiatives.What Are Latest Mergers And Acquisitions In The Cell Biology Cloud Computing Market?
In August 2023, Ginkgo Bioworks Holdings, Inc., a US-based synthetic biology company specializing in cell programming and biological engineering, partnered with Google Cloud to build a next-generation artificial intelligence platform for biological engineering and biosecurity. Through this strategic partnership, Ginkgo selected Google Cloud as its primary cloud provider to accelerate the development of large-scale machine learning models for genomics and synthetic biology using technologies. The collaboration aims to enable large-scale analysis of biological data, advance drug discovery and gene therapy development and strengthen biosecurity capabilities. Google. is US-based provides extensive cloud computing services specifically tailored for cell biology, genomics, and life sciences research.Regional Insights
North America was the largest region in the cell biology cloud computing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Cell Biology Cloud Computing Market?
The cell biology cloud computing market consists of revenues earned by entities by providing services such as simulation services, computational workflow management, cloud-based collaboration, and virtual lab environments. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell biology cloud computing market includes sales of data center racks, cooling systems, and specialized laboratory computers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data And Analysis Are Included In The Cell Biology Cloud Computing Market Report 2026?
The cell biology cloud computing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell biology cloud computing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Cell Biology Cloud Computing Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.56 billion |
| Revenue Forecast In 2035 | $7.9 billion |
| Growth Rate | CAGR of 14.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Component, Deployment Model, Application, End-Use Industry |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Siemens AG, Roche Holding AG, Thermo Fisher Scientific Inc, Illumina Inc, QIAGEN Digital Insights, PathAI Inc, LabVantage Solutions Inc, SOPHiA GENETICS SA, Emerald Cloud Lab Inc, Metagenomi Inc, DNAnexus Inc, L7 Informatics Inc, Seqera Labs Inc, Pivot Bio Inc, Genestack Ltd, BioBam Bioinformatics SL, CureMatch Inc, MolecularMatch Inc, Basepair Technologies Inc, and Lamin Labs Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
